Artivion (AORT) Interest & Investment Income (2010 - 2026)
Artivion (AORT) posted Interest & Investment Income of $205000.0 for Q1 2026, down 34.08% on a QoQ basis from $311000.0 in Q4 2025, and up 42.36% year-over-year from $144000.0 in Q1 2025.
Artivion (AORT) Interest & Investment Income (2010 - 2026) Analysis & Trends
Artivion's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $205000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 42.36% year-over-year to $205000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $824000.0 (down 33.39% YoY) and the FY2025 annual result came in at $763000.0, down 47.99% from the prior year.
- Interest & Investment Income was $205000.0 for Q1 2026 at Artivion, down from $311000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $398000.0 in Q4 2023 and bottomed at $16000.0 in Q1 2022.
- A 5-year average of $215235.3 and a median of $240000.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 783.33% — and 2025, when it sank 80.74%.
- Artivion's Interest & Investment Income stood at $61000.0 in 2022, then jumped by 552.46% to $398000.0 in 2023, then decreased by 6.03% to $374000.0 in 2024, then declined by 16.84% to $311000.0 in 2025, then tumbled by 34.08% to $205000.0 in 2026.
- Business Quant data shows AORT's Interest & Investment Income at $205000.0 in Q1 2026, $311000.0 in Q4 2025, and $240000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Artivion | 1.26 Bn | 1.20 Bn | 75.45 Mn | 205,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205,000.00 |
| Dec 31, 2025 | 311,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 144,000.00 |
| Dec 31, 2024 | 374,000.00 |
| Sep 30, 2024 | 366,000.00 |
| Jun 30, 2024 | 353,000.00 |
| Mar 31, 2024 | 374,000.00 |
| Dec 31, 2023 | 398,000.00 |
| Sep 30, 2023 | 339,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 61,000.00 |
| Sep 30, 2022 | 40,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | 19,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 18,000.00 |